SESTD1-ACMSD Fusion FISH Probe
The SESTD1-ACMSD Fusion FISH Probe is used to confirm a fusion of the SESTD1 and ACMSD genes. The fusion of the SESTD1 and ACMSD genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SESTD1-ACMSD-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SESTD1-ACMSD-20-AQAQ | 20 (40 μL) | 200 μL |
|
SESTD1 Gene Summary
The SEC14 And Spectrin Domain Containing 1 (SESTD1) gene is located on chr2 :179966418-180129350 at 2q31.2.
Gene Name: SEC14 And Spectrin Domain Containing 1
Chromosome: CHR2: 179966418 -180129350
Locus: 2q31.2
ACMSD Gene Summary
The neuronal excitotoxin quinolinate is an intermediate in the de novo synthesis pathway of NAD from tryptophan, and has been implicated in the pathogenesis of several neurodegenerative disorders. Quinolinate is derived from alpha-amino-beta-carboxy-muconate-epsilon-semialdehyde (ACMS). ACMSD (ACMS decarboxylase; EC 4.1.1.45) can divert ACMS to a benign catabolite and thus prevent the accumulation of quinolinate from ACMS.[supplied by OMIM, Oct 2004]
Gene Name: Aminocarboxymuconate Semialdehyde Decarboxylase
Chromosome: CHR2: 135596185 -135659602
Locus: 2q21.3
Gene Diseases
The SESTD1 ACMSD Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|